ArticleOncotarget2016

Oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX) as second-line therapy for patients with advanced urothelial cancer.

Sheng Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.